スポンサーリンク
Division Of Rheumatology And Clinical Immunology Department Of Internal Medicine Faculty Of Medicine | 論文
- Clinical and Radiological Features of Acute-Onset Diffuse Interstitial Lung Diseases in Patients with Rheumatoid Arthritis Receiving Treatment with Biological Agents: Importance of Pneumocystis Pneumonia in Japan Revealed by a Multicenter Study
- Clinical and histopathological features of myopathies in Japanese patients with anti-SRP autoantibodies
- Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan : one-year clinical outcomes (RECONFIRM-2)
- Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan (RECONFIRM)
- Differences between the Health Assessment Questionnaire Disability Index (HAQ-DI) and the modified HAQ (mHAQ) score before and after infliximab treatment in patients with rheumatoid arthritis
- Development and validation of handy rheumatoid activity score with 38 joints (HRAS38) in rheumatoid arthritis patients receiving infliximab
- Impact of TNF inhibitors on rheumatoid arthritis
- Efficacy and safety of bucillamine, a D-penicillamine analogue, in patients with active rheumatoid arthritis
- Anti-TNF Biological Agents in Rheumatoid Arthritis and Other Inflammatory Diseases
- Efficacy and tolerability of tocilizumab in rheumatoid arthritis patients seen in daily clinical practice in Japan : results from a retrospective study (REACTION study)
- Structural damages disturb functional improvement in patients with rheumatoid arthritis treated with etanercept
- Effectiveness and safety of adalimumab in Japanese patients with rheumatoid arthritis : retrospective analyses of data collected during the first year of adalimumab treatment in routine clinical practice (HARMONY study)
- A retrospective study of serum KL-6 levels during treatment with biological disease-modifying antirheumatic drugs in rheumatoid arthritis patients : a report from the Ad Hoc Committee for Safety of Biological DMARDs of the Japan College of Rheumatology